Cargando…
Efficacy of hyperthermic intraperitoneal chemotherapy and interval debulking surgery in women with advanced uterine serous carcinoma
OBJECTIVE(S): To investigate the efficacy and safety of hyperthermic intraperitoneal chemotherapy (HIPEC) at the time of iterval debulking surgery (IDS) in women with advanced uterine serous carcinoma (USC) following neoadjuvant chemotherapy (NACT). METHODS: An IRB-approved single-institution prospe...
Autores principales: | Chambers, Laura M., Chau, Danielle, Yao, Meng, Costales, Anthony B., Rose, Peter G., Michener, Chad M., Debernardo, Robert, Vargas, Roberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8567198/ https://www.ncbi.nlm.nih.gov/pubmed/34761096 http://dx.doi.org/10.1016/j.gore.2021.100876 |
Ejemplares similares
-
Assessing feasibility and perioperative outcomes with minimally invasive surgery compared with laparotomy for interval debulking surgery with hyperthermic intraperitoneal chemotherapy for advanced epithelial ovarian cancer
por: Morton, Molly, et al.
Publicado: (2021) -
Assessment of travel distance for hyperthermic intraperitoneal chemotherapy in women with ovarian cancer
por: Chambers, Laura M., et al.
Publicado: (2022) -
Mechanistic Insights on Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
por: Huffman, Olivia G., et al.
Publicado: (2023) -
Debulking surgery and hyperthermic intraperitoneal chemotherapy in the management of a recurrent aggressive uterine myxoid leiomyosarcoma with peritoneal dissemination
por: Inoue, Daisuke, et al.
Publicado: (2015) -
Interval debulking surgery with or without hyperthermic intraperitoneal chemotherapy in advanced-stage ovarian cancer: Single-institution cohort study
por: Lee, Yong Jae, et al.
Publicado: (2022)